<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Atrial Fibrillation Blog</title>
	<atom:link href="http://atrialfibrillationblog.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://atrialfibrillationblog.com</link>
	<description>From StopAfib.org - For Afib Patients, By Afib Patients</description>
	<lastBuildDate>Fri, 03 Feb 2012 07:55:56 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Atrial Fibrillation &amp; Anticoagulants&#8211;StopAfib.org interviews Dr. Daniel Singer</title>
		<link>http://atrialfibrillationblog.com/atrial-fibrillation-anticoagulants-stopafib-org-interviews-dr-daniel-singer/</link>
		<comments>http://atrialfibrillationblog.com/atrial-fibrillation-anticoagulants-stopafib-org-interviews-dr-daniel-singer/#comments</comments>
		<pubDate>Fri, 03 Feb 2012 07:55:56 +0000</pubDate>
		<dc:creator>Mellanie</dc:creator>
				<category><![CDATA[Videos]]></category>
		<category><![CDATA[afib]]></category>
		<category><![CDATA[anticoagulants]]></category>
		<category><![CDATA[apixaban]]></category>
		<category><![CDATA[ARISTOTLE]]></category>
		<category><![CDATA[atrial fibrillation]]></category>
		<category><![CDATA[AVERROES]]></category>
		<category><![CDATA[coumadin]]></category>
		<category><![CDATA[dabigatran]]></category>
		<category><![CDATA[edoxaban]]></category>
		<category><![CDATA[Eliquis]]></category>
		<category><![CDATA[Pradaxa]]></category>
		<category><![CDATA[Stroke]]></category>
		<category><![CDATA[warfarin]]></category>

		<guid isPermaLink="false">http://atrialfibrillationblog.com/atrial-fibrillation-anticoagulants-stopafib-org-interviews-dr-daniel-singer/</guid>
		<description><![CDATA[StopAfib.org interviews Dr. Daniel Singer of Harvard Medical School. Find more information on this topic, and Dr. Singer, at: www.stopafib.org Dr. Singer led a symposium on atrial fibrillation stroke prevention at Boston Atrial Fibrillation Symposium 2012. In this video interview, Dr. Singer shared with StopAfib.org information from that symposium. He provided an update on rivaroxaban [...]]]></description>
		<wfw:commentRss>http://atrialfibrillationblog.com/atrial-fibrillation-anticoagulants-stopafib-org-interviews-dr-daniel-singer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Atrial Fibrillation &amp; Stroke Prevention&#8211;StopAfib.org interviews Dr. Daniel Singer</title>
		<link>http://atrialfibrillationblog.com/atrial-fibrillation-stroke-prevention-stopafib-org-interviews-dr-daniel-singer/</link>
		<comments>http://atrialfibrillationblog.com/atrial-fibrillation-stroke-prevention-stopafib-org-interviews-dr-daniel-singer/#comments</comments>
		<pubDate>Fri, 03 Feb 2012 04:41:38 +0000</pubDate>
		<dc:creator>Mellanie</dc:creator>
				<category><![CDATA[Videos]]></category>
		<category><![CDATA[afib]]></category>
		<category><![CDATA[atrial fibrillation]]></category>
		<category><![CDATA[Daniel Singer]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[rivaroxaban]]></category>
		<category><![CDATA[ROCKET AF trial]]></category>
		<category><![CDATA[Stroke]]></category>
		<category><![CDATA[stroke prevention]]></category>

		<guid isPermaLink="false">http://atrialfibrillationblog.com/atrial-fibrillation-stroke-prevention-stopafib-org-interviews-dr-daniel-singer/</guid>
		<description><![CDATA[StopAfib.org interviews Dr. Daniel Singer, of Harvard Medical School. Find more information on this topic, Dr. Singer, and a transcript of the interview, at: www.stopafib.org In this video interview, Dr. Singer discussed topics covered in the stroke prevention in atrial fibrillation symposium he moderated at the Boston AF Symposium 2011. The topics discussed included the [...]]]></description>
		<wfw:commentRss>http://atrialfibrillationblog.com/atrial-fibrillation-stroke-prevention-stopafib-org-interviews-dr-daniel-singer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Update on Atrial Fibrillation Stroke Prevention — Video interview with Dr. Daniel Singer of Harvard</title>
		<link>http://atrialfibrillationblog.com/update-on-atrial-fibrillation-stroke-prevention-video-interview-with-dr-daniel-singer-of-harvard/</link>
		<comments>http://atrialfibrillationblog.com/update-on-atrial-fibrillation-stroke-prevention-video-interview-with-dr-daniel-singer-of-harvard/#comments</comments>
		<pubDate>Wed, 25 Jan 2012 13:11:20 +0000</pubDate>
		<dc:creator>Mellanie</dc:creator>
				<category><![CDATA[Anticoagulation]]></category>
		<category><![CDATA[Audio/Video]]></category>
		<category><![CDATA[Medication]]></category>
		<category><![CDATA[Resources]]></category>
		<category><![CDATA[Stroke]]></category>
		<category><![CDATA[Study]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[afib stroke]]></category>
		<category><![CDATA[anticoagulants]]></category>
		<category><![CDATA[apixaban]]></category>
		<category><![CDATA[atrial fibrillation stroke prevention]]></category>
		<category><![CDATA[coumadin]]></category>
		<category><![CDATA[dabigatran]]></category>
		<category><![CDATA[Dr Daniel Singer]]></category>
		<category><![CDATA[edoxaban]]></category>
		<category><![CDATA[rivaroxaban]]></category>
		<category><![CDATA[video]]></category>
		<category><![CDATA[warfarin]]></category>

		<guid isPermaLink="false">http://atrialfibrillationblog.com/?p=1223</guid>
		<description><![CDATA[In this interview, Dr. Daniel Singer updates us on the new anticoagulants for atrial fibrillation stroke prevention that he presented about at Boston Atrial Fibrillation Symposium. He provided an update on rivaroxaban (Xarelto), apixaban (Eliquis), dabigatran (Pradaxa), and edoxaban, and mentioned that all were better than warfarin (Coumadin) in preventing intracranial bleeding (bleeding in the [...]]]></description>
		<wfw:commentRss>http://atrialfibrillationblog.com/update-on-atrial-fibrillation-stroke-prevention-video-interview-with-dr-daniel-singer-of-harvard/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New HRS/EHRA/ECAS Atrial Fibrillation Ablation Guidelines Presented by Dr. Hugh Calkins of Johns Hopkins — Video</title>
		<link>http://atrialfibrillationblog.com/new-hrsehraecas-atrial-fibrillation-ablation-guidelines-presented-by-dr-hugh-calkins-of-johns-hopkins-video/</link>
		<comments>http://atrialfibrillationblog.com/new-hrsehraecas-atrial-fibrillation-ablation-guidelines-presented-by-dr-hugh-calkins-of-johns-hopkins-video/#comments</comments>
		<pubDate>Mon, 23 Jan 2012 20:05:22 +0000</pubDate>
		<dc:creator>Mellanie</dc:creator>
				<category><![CDATA[Anticoagulation]]></category>
		<category><![CDATA[Audio/Video]]></category>
		<category><![CDATA[Catheter ablation]]></category>
		<category><![CDATA[Resources]]></category>
		<category><![CDATA[Stroke]]></category>
		<category><![CDATA[Surgery]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[afib surgical ablation]]></category>
		<category><![CDATA[anticoagulant]]></category>
		<category><![CDATA[atrial fibrillation catheter ablation]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[Dr. Hugh Calkins]]></category>
		<category><![CDATA[guidelines]]></category>

		<guid isPermaLink="false">http://atrialfibrillationblog.com/?p=1180</guid>
		<description><![CDATA[At Boston Atrial Fibrillation Symposium 2012, Dr. Hugh Calkins, electrophysiologist at Johns Hopkins, presented the new 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation, which will replace the original guidelines that were published in 2007. Instead of simply rewriting sections that have changed, the writing committee, which was made up [...]]]></description>
		<wfw:commentRss>http://atrialfibrillationblog.com/new-hrsehraecas-atrial-fibrillation-ablation-guidelines-presented-by-dr-hugh-calkins-of-johns-hopkins-video/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Boston Atrial Fibrillation Symposium 2012 Recap and Notes – Guest Posts by Dr. John Mandrola</title>
		<link>http://atrialfibrillationblog.com/boston-atrial-fibrillation-symposium-2012-recap-and-notes-guest-posts-by-dr-john-mandrola/</link>
		<comments>http://atrialfibrillationblog.com/boston-atrial-fibrillation-symposium-2012-recap-and-notes-guest-posts-by-dr-john-mandrola/#comments</comments>
		<pubDate>Thu, 19 Jan 2012 18:13:43 +0000</pubDate>
		<dc:creator>Mellanie</dc:creator>
				<category><![CDATA[Anticoagulation]]></category>
		<category><![CDATA[Catheter ablation]]></category>
		<category><![CDATA[Medication]]></category>
		<category><![CDATA[Prevention]]></category>
		<category><![CDATA[Sleep Apnea]]></category>
		<category><![CDATA[Stroke]]></category>
		<category><![CDATA[Study]]></category>
		<category><![CDATA[Surgery]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[afib stroke]]></category>
		<category><![CDATA[atrial fibrillation stroke prevention]]></category>
		<category><![CDATA[focal beats]]></category>
		<category><![CDATA[pulmonary vein isolation]]></category>
		<category><![CDATA[reconnection]]></category>
		<category><![CDATA[rotors]]></category>
		<category><![CDATA[surgical ablation]]></category>

		<guid isPermaLink="false">http://atrialfibrillationblog.com/?p=1176</guid>
		<description><![CDATA[Dr. John Mandrola, a cardiac electrophysiologist in Louisville, Kentucky, who blogs at Dr. John M, live-blogged the 2012 Boston Atrial Fibrillation Symposium. He has given us permission to reprint his blog posts for the afib community. You will find them here: Recap of Boston Atrial Fibrillation Symposium 2012 – Guest Posts by Dr. John Mandrola [...]]]></description>
		<wfw:commentRss>http://atrialfibrillationblog.com/boston-atrial-fibrillation-symposium-2012-recap-and-notes-guest-posts-by-dr-john-mandrola/feed/</wfw:commentRss>
		<slash:comments>3</slash:comments>
		</item>
		<item>
		<title>Atrial Fibrillation &amp; Catheter Ablation&#8211;StopAfib.org interviews Dr. Sanjiv Narayan</title>
		<link>http://atrialfibrillationblog.com/atrial-fibrillation-catheter-ablation-stopafib-org-interviews-dr-sanjiv-narayan/</link>
		<comments>http://atrialfibrillationblog.com/atrial-fibrillation-catheter-ablation-stopafib-org-interviews-dr-sanjiv-narayan/#comments</comments>
		<pubDate>Wed, 18 Jan 2012 07:53:04 +0000</pubDate>
		<dc:creator>Mellanie</dc:creator>
				<category><![CDATA[Videos]]></category>
		<category><![CDATA[afib]]></category>
		<category><![CDATA[atrial fibrillation]]></category>
		<category><![CDATA[Catheter ablation]]></category>
		<category><![CDATA[FIRM trial]]></category>

		<guid isPermaLink="false">http://atrialfibrillationblog.com/atrial-fibrillation-catheter-ablation-stopafib-org-interviews-dr-sanjiv-narayan/</guid>
		<description><![CDATA[StopAfib.org interviews Dr. Sanjiv Narayan of the University of California at San Diego. Find a transcript of the interview, and more on Dr. Narayan and the FIRM trial at: http://www.stopafib.org/newsitem.cfm/NEWSID/379 In this video interview at the American Heart Association Scientific Sessions 2011, Dr. Narayan discussed the high success rate of the FIRM trial of focal [...]]]></description>
		<wfw:commentRss>http://atrialfibrillationblog.com/atrial-fibrillation-catheter-ablation-stopafib-org-interviews-dr-sanjiv-narayan/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>Atrial Fibrillation &amp; Stroke Prediction&#8211;StopAfib.org interviews Prof. Gregory Lip</title>
		<link>http://atrialfibrillationblog.com/atrial-fibrillation-stroke-prediction-stopafib-org-interviews-prof-gregory-lip/</link>
		<comments>http://atrialfibrillationblog.com/atrial-fibrillation-stroke-prediction-stopafib-org-interviews-prof-gregory-lip/#comments</comments>
		<pubDate>Wed, 18 Jan 2012 06:34:33 +0000</pubDate>
		<dc:creator>Mellanie</dc:creator>
				<category><![CDATA[Videos]]></category>
		<category><![CDATA[afib]]></category>
		<category><![CDATA[anticoagulant]]></category>
		<category><![CDATA[aspirin]]></category>
		<category><![CDATA[atrial fibrillation]]></category>
		<category><![CDATA[CHADS2]]></category>
		<category><![CDATA[coumadin]]></category>
		<category><![CDATA[Stroke]]></category>
		<category><![CDATA[warfarin]]></category>

		<guid isPermaLink="false">http://atrialfibrillationblog.com/atrial-fibrillation-stroke-prediction-stopafib-org-interviews-prof-gregory-lip/</guid>
		<description><![CDATA[StopAfib.org interviews Prof. Gregory Lip, of the University of Birmingham (UK) Find more information on the CHADS2 scoring system, and on Prof. Lip, at: http://www.stopafib.org/newsitem.cfm/NEWSID/369 In this video interview, Dr. Lip discussed the CHA2DS2-VASc tool, which was recently adopted by the European Society of Cardiology Atrial Fibrillation Guidelines for predicting stroke risk in atrial fibrillation. [...]]]></description>
		<wfw:commentRss>http://atrialfibrillationblog.com/atrial-fibrillation-stroke-prediction-stopafib-org-interviews-prof-gregory-lip/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Atrial Fibrillation &amp; Gender Differences&#8211;StopAfib.org interviews Dr. John Mandrola</title>
		<link>http://atrialfibrillationblog.com/atrial-fibrillation-gender-differences-stopafib-org-interviews-dr-john-mandrola-8/</link>
		<comments>http://atrialfibrillationblog.com/atrial-fibrillation-gender-differences-stopafib-org-interviews-dr-john-mandrola-8/#comments</comments>
		<pubDate>Tue, 17 Jan 2012 01:13:10 +0000</pubDate>
		<dc:creator>Mellanie</dc:creator>
				<category><![CDATA[Videos]]></category>
		<category><![CDATA[ablation]]></category>
		<category><![CDATA[afib]]></category>
		<category><![CDATA[atrial fibrillation]]></category>
		<category><![CDATA[gender differences]]></category>
		<category><![CDATA[John Mandrola]]></category>

		<guid isPermaLink="false">http://atrialfibrillationblog.com/atrial-fibrillation-gender-differences-stopafib-org-interviews-dr-john-mandrola-8/</guid>
		<description><![CDATA[StopAfib.org interviews Dr. John Mandrola of Baptist Hospital East in Louisville, KY. Trancripts and more information on Dr. Mandrola are available at: http://www.stopafib.org/newsitem.cfm/NEWSID/374 In this video interview at the American Heart Association Scientific Sessions 2011, Dr. John Mandrola discussed the poster he presented there about gender-specific results of atrial fibrillation ablation in a private practice [...]]]></description>
		<wfw:commentRss>http://atrialfibrillationblog.com/atrial-fibrillation-gender-differences-stopafib-org-interviews-dr-john-mandrola-8/feed/</wfw:commentRss>
		<slash:comments>3</slash:comments>
		</item>
		<item>
		<title>Atrial Fibrillation &amp; Anticoagulants&#8211;StopAfib.org interviews Dr. Elaine Hylek</title>
		<link>http://atrialfibrillationblog.com/atrial-fibrillation-anticoagulants-stopafib-org-interviews-dr-elaine-hylek/</link>
		<comments>http://atrialfibrillationblog.com/atrial-fibrillation-anticoagulants-stopafib-org-interviews-dr-elaine-hylek/#comments</comments>
		<pubDate>Sun, 15 Jan 2012 02:04:14 +0000</pubDate>
		<dc:creator>Mellanie</dc:creator>
				<category><![CDATA[Videos]]></category>
		<category><![CDATA[afib]]></category>
		<category><![CDATA[Apixaaban]]></category>
		<category><![CDATA[ARISTOTLE trial]]></category>
		<category><![CDATA[atrial fibrillation]]></category>
		<category><![CDATA[Boston Medical Center]]></category>
		<category><![CDATA[dabigatran]]></category>
		<category><![CDATA[edoxaban]]></category>
		<category><![CDATA[Elaine Hylek]]></category>
		<category><![CDATA[Pradaxa]]></category>
		<category><![CDATA[rivaroxaban]]></category>
		<category><![CDATA[Stroke]]></category>
		<category><![CDATA[warfarin]]></category>
		<category><![CDATA[Xarelto]]></category>

		<guid isPermaLink="false">http://atrialfibrillationblog.com/atrial-fibrillation-anticoagulants-stopafib-org-interviews-dr-elaine-hylek/</guid>
		<description><![CDATA[StopAfib.org interviews Dr. Elaine Hylek of Boston University. A transcript of this video, as well as additional information about the topics discussed, and Dr. Hylek, can be found at: http://www.stopafib.org/newsitem.cfm/NEWSID/349 In this video interview, Dr. Elaine Hylek of Boston University discusses new anticoagulant drugs for stroke prevention in atrial fibrillation. For many years, warfarin (Coumadin) [...]]]></description>
		<wfw:commentRss>http://atrialfibrillationblog.com/atrial-fibrillation-anticoagulants-stopafib-org-interviews-dr-elaine-hylek/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Catheter &amp; Surgical Ablation Guideline Updates&#8211;StopAfib.org interviews Dr. Hugh Calkins</title>
		<link>http://atrialfibrillationblog.com/catheter-surgical-ablation-guideline-updates-stopafib-org-interviews-dr-hugh-calkins/</link>
		<comments>http://atrialfibrillationblog.com/catheter-surgical-ablation-guideline-updates-stopafib-org-interviews-dr-hugh-calkins/#comments</comments>
		<pubDate>Sun, 15 Jan 2012 01:36:05 +0000</pubDate>
		<dc:creator>Mellanie</dc:creator>
				<category><![CDATA[Videos]]></category>
		<category><![CDATA[ablation guidelines]]></category>
		<category><![CDATA[afib]]></category>
		<category><![CDATA[atrial fibrillation]]></category>
		<category><![CDATA[Catheter ablation]]></category>
		<category><![CDATA[Hugh Calkins]]></category>
		<category><![CDATA[Johns Hopkins]]></category>
		<category><![CDATA[Stop]]></category>
		<category><![CDATA[surgical ablation]]></category>

		<guid isPermaLink="false">http://atrialfibrillationblog.com/catheter-surgical-ablation-guideline-updates-stopafib-org-interviews-dr-hugh-calkins/</guid>
		<description><![CDATA[StopAfib.org interviews Dr. Hugh Calkins, electrophysiologist at Johns Hopkins Hospital. In this video, Dr. Calkins discussed the current effort to update and rewrite the HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation, which was published in 2007. The goal is to present the new guidelines at the Boston Atrial Fibrillation Symposium [...]]]></description>
		<wfw:commentRss>http://atrialfibrillationblog.com/catheter-surgical-ablation-guideline-updates-stopafib-org-interviews-dr-hugh-calkins/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

<!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Minified using disk: basic
Page Caching using disk: enhanced

Served from: atrialfibrillationblog.com @ 2012-02-04 21:50:30 -->
